Shopping Cart
- Remove All
Your shopping cart is currently empty
Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $347 | In Stock | |
| 5 mg | $872 | In Stock | |
| 10 mg | $1,390 | In Stock | |
| 25 mg | $1,980 | Backorder | |
| 50 mg | $2,780 | Backorder | |
| 100 mg | $3,750 | Backorder |
| Description | Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia. |
| In vivo | Bococizumab (0, 10, 30, and 100 mg/kg; i.v.; Pregnant Sprague-Dawley (SD) rats) decreases maternal and fetal cholesterol and shows good tolerance and no effects on ovarian or uterine parameters.[2] |
| Synonyms | RN316, PF-04950615 |
| Molecular Weight | 145.0 kDa |
| Cas No. | 1407495-02-6 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.